Pyrazolopyrimidines as therapeutic agents
US6921763B2 · kind B2 · utility
232Cited by
6References
132Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2001 |
| Grant date | Jul 26, 2005 |
| Priority date | — |
| Expiry date | Jan 10, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.